West Pharmaceutical Services Current Ratio 2010-2022 | WST
Current and historical current ratio for West Pharmaceutical Services (WST) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. West Pharmaceutical Services current ratio for the three months ending March 31, 2022 was 2.89.
| West Pharmaceutical Services Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2022-03-31 |
$1.69B |
$0.59B |
2.89 |
| 2021-12-31 |
$1.74B |
$0.59B |
2.93 |
| 2021-09-30 |
$1.60B |
$0.56B |
2.86 |
| 2021-06-30 |
$1.48B |
$0.47B |
3.13 |
| 2021-03-31 |
$1.33B |
$0.48B |
2.75 |
| 2020-12-31 |
$1.37B |
$0.50B |
2.73 |
| 2020-09-30 |
$1.24B |
$0.45B |
2.77 |
| 2020-06-30 |
$1.11B |
$0.38B |
2.96 |
| 2020-03-31 |
$0.98B |
$0.34B |
2.84 |
| 2019-12-31 |
$1.06B |
$0.34B |
3.10 |
| 2019-09-30 |
$1.00B |
$0.34B |
3.00 |
| 2019-06-30 |
$0.94B |
$0.31B |
3.02 |
| 2019-03-31 |
$0.87B |
$0.30B |
2.88 |
| 2018-12-31 |
$0.89B |
$0.28B |
3.15 |
| 2018-09-30 |
$0.85B |
$0.29B |
2.94 |
| 2018-06-30 |
$0.77B |
$0.29B |
2.67 |
| 2018-03-31 |
$0.74B |
$0.26B |
2.82 |
| 2017-12-31 |
$0.74B |
$0.28B |
2.66 |
| 2017-09-30 |
$0.78B |
$0.30B |
2.59 |
| 2017-06-30 |
$0.72B |
$0.29B |
2.48 |
| 2017-03-31 |
$0.65B |
$0.26B |
2.54 |
| 2016-12-31 |
$0.64B |
$0.24B |
2.66 |
| 2016-09-30 |
$0.66B |
$0.24B |
2.78 |
| 2016-06-30 |
$0.66B |
$0.24B |
2.75 |
| 2016-03-31 |
$0.63B |
$0.24B |
2.62 |
| 2015-12-31 |
$0.67B |
$0.31B |
2.14 |
| 2015-09-30 |
$0.68B |
$0.30B |
2.27 |
| 2015-06-30 |
$0.68B |
$0.31B |
2.17 |
| 2015-03-31 |
$0.63B |
$0.30B |
2.11 |
| 2014-12-31 |
$0.66B |
$0.25B |
2.61 |
| 2014-09-30 |
$0.68B |
$0.24B |
2.80 |
| 2014-06-30 |
$0.69B |
$0.22B |
3.10 |
| 2014-03-31 |
$0.69B |
$0.23B |
3.02 |
| 2013-12-31 |
$0.65B |
$0.24B |
2.75 |
| 2013-09-30 |
$0.64B |
$0.25B |
2.61 |
| 2013-06-30 |
$0.61B |
$0.22B |
2.80 |
| 2013-03-31 |
$0.59B |
$0.21B |
2.83 |
| 2012-12-31 |
$0.56B |
$0.26B |
2.13 |
| 2012-09-30 |
$0.56B |
$0.28B |
2.02 |
| 2012-06-30 |
$0.52B |
$0.32B |
1.62 |
| 2012-03-31 |
$0.50B |
$0.30B |
1.66 |
| 2011-12-31 |
$0.47B |
$0.24B |
1.94 |
| 2011-09-30 |
$0.50B |
$0.23B |
2.20 |
| 2011-06-30 |
$0.51B |
$0.19B |
2.65 |
| 2011-03-31 |
$0.48B |
$0.18B |
2.63 |
| 2010-12-31 |
$0.44B |
$0.17B |
2.57 |
| 2010-09-30 |
$0.44B |
$0.16B |
2.79 |
| 2010-06-30 |
$0.40B |
$0.16B |
2.55 |
| 2010-03-31 |
$0.41B |
$0.18B |
2.20 |
| 2009-12-31 |
$0.40B |
$0.17B |
2.32 |
| 2009-09-30 |
$0.40B |
$0.16B |
2.45 |
| 2009-06-30 |
$0.40B |
$0.16B |
2.45 |
| 2009-03-31 |
$0.36B |
$0.14B |
2.57 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$21.960B |
$2.832B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
